Concentrates

Washington lawmakers are considering raising taxes on highly potent cannabis products, proposing a 50% tax rate for products containing between 35% and 60% THC and a 65% tax rate for products exceeding 60% THC.

The Vermont Cannabis Control Board is recommending the state drop THC potency caps for cannabis concentrates, arguing the limits will create a black market monopoly and lead cannabis companies to dilute their products with potentially dangerous filler.

The Vermont House has passed a bill aimed at capping the potency of cannabis concentrates at 60% THC.

Colorado’s new medical cannabis rules, which take effect starting January 1, include stricter cannabis purchase limits for patients and a ban on marketing medical cannabis to people under age 21.

The Minnesota Court of Appeals upheld the conviction of someone arrested with hemp CBD vape cartridges, claiming the state’s hemp law does not extend to liquid mixtures containing THC (even if under the 0.3% THC threshold).

South Dakota approved most of the Department of Health’s rules for the state’s voter-approved medical cannabis program but rejected some proposals including limiting patient possession of high-potency cannabis products.

This article explores two questions: what exactly is solventless cannabis extraction, and is driving the popularity of solventless cannabis products?

Maine set a new adult-use cannabis sales record in June at $6,470,936.

A new bill signed by Colorado Gov. Jared Polis on Thursday limits the amount of concentrate adult medical cannabis patients can buy in one day and places new rules on patients who are younger than 21-years-old.

The Texas Senate failed to consider a House-approved bill to reduce the penalties for possessing cannabis concentrate products before the state’s legislative session ended on Monday.

Texas lawmakers approved legislation over the weekend to study the effectiveness of psychedelics in treating PTSD among veterans and to reduce possession penalties for cannabis concentrates.

A Colorado bill is seeking to reduce the amount of concentrates that medical cannabis patients ages 18-20 can purchase in an effort to prevent the diversion of such products to Colorado’s youth.